Key result
Phosphocreatine usage shows prospects in treating heart rhythm disorders and heart failure associated with myocardial ischemia and reperfusion injury based on literature review.
Why the study?
The study was conducted to identify pathophysiological peculiarities of myocardial reperfusion injury and evaluate ways to reduce it based on a literature review.
Does phosphocreatine reduce myocardial reperfusion injury and remodeling in patients with myocardial infarction?
Does phosphocreatine reduce myocardial reperfusion injury and remodeling in patients with myocardial infarction?
This literature review suggests that phosphocreatine may be a promising agent for preventing and correcting myocardial reperfusion injury and associated arrhythmias or heart failure.
Answers are grounded in this paper and cite their sources.
Phosphocreatine may aid reperfusion injury management in MI; hypothesis-generating and requires prospective trials before adoption.
OBJECTIVE: The aim: To identify pathophysiological peculiarities of myocardial reperfusion injury and ways of its reduction based on the literature data analysis. PATIENTS AND METHODS: Materials and methots: This literature review was made by searching the PubMed database using key words . Additional data were sought in the Google search engine by entering key words: " risk factors, ischemic heart disease, arrhythmia, sudden cardiac death, heart rhythm, heart failure." in the Polish, English, Russian and Ukrainian language versions. CONCLUSION: Conclusions: Considering conducted data analysis, provided data indicate the prospects of phosphocreatine usage in treatment scheme of heart rhythm disorders and heart failure on the background of myocardial ischemia and elimination of reperfusion injury and myocardial remodeling consequences.
No takes yet. Share an insight, caveat, or question.
Andriy I. Vytrykhovskyi (2022) conducted a review in Myocardial reperfusion injury in acute myocardial infarction. Phosphocreatine was evaluated. Phosphocreatine usage shows prospects in treating heart rhythm disorders and heart failure associated with myocardial ischemia and reperfusion injury based on literature review.
Synapse has enriched 10 related papers. Consider them for comparative context: